ASRT vs RF
Assertio Therapeutics Inc (ASRT) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
RF (RF) common stock.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
RF does not have a complete income-statement cache yet.
ASRT currently screens at market cap $151.5M. RF currently screens at market cap $0.
Not investment advice. Open the ASRT and RF stock pages for the full models.
Not investment advice.